Dycom Industries Total Cost of Revenue increased by 32.3% to $1.58B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 56.1%, from $1.01B to $1.58B. Over 4 years (FY 2022 to FY 2026), Total Cost of Revenue shows an upward trend with a 13.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $620.01M | $651.37M | $705.87M | $656.63M | $745.73M | $797.98M | $850.90M | $765.66M | $853.37M | $830.41M | $886.66M | $791.38M | $921.64M | $952.88M | $1.01B | $887.95M | $1.01B | $1.07B | $1.13B | $1.19B | $1.58B |
| QoQ Change | — | +5.1% | +8.4% | -7.0% | +13.6% | +7.0% | +6.6% | -10.0% | +11.5% | -2.7% | +6.8% | -10.7% | +16.5% | +3.4% | +5.7% | -11.9% | +13.9% | +5.9% | +5.7% | +5.4% | +32.3% |
| YoY Change | — | — | — | — | +20.3% | +22.5% | +20.5% | +16.6% | +14.4% | +4.1% | +4.2% | +3.4% | +8.0% | +14.7% | +13.6% | +12.2% | +9.7% | +12.3% | +12.3% | +34.3% | +56.1% |